Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Cited by (1,000)

Items 401–500 of 1,000

1. Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
   Jennifer A. White, Francesco Roberto Simonetti, Subul A. Beg, Natalie F. McMyn, Weiwei Dai, Niklas Bachmann, Jun Lai, William C. Ford, Christina Bunch, Joyce L Jones et al. · 2022 · Proceedings of the National Academy of Sciences
2. Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes
   Michael J Endres, Salman Jaffer, Beth Haggarty, Julie Davis Turner, Benjamin J. Doranz, Peter James O'Brien, Dennis L. Kolson, James A. Hoxie · 1997 · Science
3. An Evolutionary Role for HIV Latency in Enhancing Viral Transmission
   Igor M. Rouzine, Ariel D. Weinberger, Leor S. Weinberger · 2015 · Cell
4. The evolution of HIV: Inferences using phylogenetics
   Eduardo Castro‐Nallar, Marcos Pérez‐Losada, Gregory F. Burton, Keith A. Crandall · 2011 · Molecular Phylogenetics and Evolution
5. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
   Lı́dia Ruiz, Jan van Lunzen, Albert Arno, Hans‐Jürgen Stellbrink, Claus Schneider, Miquel Rull, E. Castellà, Isabel Ojanguren, Douglas D. Richman, Bonaventura Clotet et al. · 1999 · AIDS
6. Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response
   Steven G. Deeks, Robert M. Grant, Terri Wrin, Ellen E. Paxinos, Teri J. Liegler, Rebecca Hoh, Jeff N. Martin, Christos J. Petropoulos · 2003 · AIDS
7. The role of cytokines in the pathogenesis and treatment of HIV infection
   Marta Catálfamo, Cécile Le Saout, Henry Clifford Lane · 2012 · Cytokine & Growth Factor Reviews
8. Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
   George K. Lewis, Anthony L. DeVico, Robert C. Gallo · 2014 · Proceedings of the National Academy of Sciences
9. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression
   Sharon M. Wahl, Teresa Greenwell‐Wild, G. Peng, Hollie Hale‐Donze, T. Mark Doherty, Diane E. Mizel, Jan Marc Orenstein · 1998 · Proceedings of the National Academy of Sciences
10. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
    Ángela Ibáñez, Teresa Puig, Johannes Elias, Bonaventura Clotet, Lı́dia Ruiz, Miguel Ángel Martı́nez · 1999 · AIDS
11. Early Initiation of Combination Antiretroviral Therapy in HIV-1-Infected Newborns Can Achieve Sustained Virologic Suppression With Low Frequency of CD4+ T Cells Carrying HIV in Peripheral Blood
    Ari Bitnun, Lindy Michelle Samson, Tae‐Wook Chun, Fatima Kakkar, Jason C. Brophy, Danielle Murray, J. Shawn Justement, Hugo Soudeyns, Mario Ostrowski, Shariq Mujib et al. · 2014 · Clinical Infectious Diseases
12. Ex VivoBioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4+T Cells from Aviremic Patients
    Adam M. Spivak, Alberto Bosque, Alfred H. Balch, David R. Smyth, Laura J. Martins, Vicente Planelles · 2015 · Antimicrobial Agents and Chemotherapy
13. An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells
    Thor A. Wagner, Jennifer L. McKernan, Nicole H. Tobin, Ken Tapia, James I. Mullins, Lisa M. Frenkel · 2012 · Journal of Virology
14. The utilization of humanized mouse models for the study of human retroviral infections
    Rachel Van Duyne, Caitlin Pedati, Irene Guendel, Lawrence Carpio, Kylene Kehn‐Hall, Mohammed Saifuddin, Fatah Kashanchi · 2009 · Retrovirology
15. Use of ESAT‐6 and CFP‐10 Antigens for Diagnosis of Extrapulmonary Tuberculosis
    Martin E. Munk, Sandra M. Arend, Inger Brock, Tom H. M. Ottenhoff, Peter Lawætz Andersen · 2001 · The Journal of Infectious Diseases
16. Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy
    Christian Lorenz Althaus, Rob J. de Boer · 2010 · Molecular Systems Biology
17. A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
    Jessica M. Conway, Daniel Coombs · 2011 · PLoS Computational Biology
18. The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance
    Ann Noë, Jean R. Plum, Chris Verhofstede · 2005 · Journal of Antimicrobial Chemotherapy
19. The central nervous system is a viral reservoir in simian immunodeficiency virus–infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral theraby
    Janice E. Clements, Ming Li, Lúcio Gama, Brandon T. Bullock, Lucy M. Carruth, Joseph L. Mankowski, M. Christine Zink · 2005 · Journal of NeuroVirology
20. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring
    Mark A. Lifson, Mehmet Ozgün Ozen, Fatih İnci, Shuqi Wang, Hakan Inan, Murat Baday, Timothy J. Henrich, Utkan Demirci · 2016 · Advanced Drug Delivery Reviews
21. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques
    Celina Monteiro Abreu, Rebecca T. Veenhuis, Claudia R. Avalos, Shelby Graham, Daymond R. Parrilla, Edna A. Ferreira, Suzanne E. Queen, Erin N. Shirk, Brandon T. Bullock, Ming Li et al. · 2019 · mBio
22. From reactivation of latent HIV‐1 to elimination of the latent reservoir: The presence of multiple barriers to viral eradication
    Liang Shan, Robert F. Siliciano · 2013 · BioEssays
23. Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
    Shailesh Kumar Choudhary, David M. Margolis · 2011 · The Annual Review of Pharmacology and Toxicology
24. Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2014 · Journal of Allergy and Clinical Immunology
25. Naturally SIV‐infected sooty mangabeys: are we closer to understanding why they do not develop AIDS?
    Guido Silvestri · 2005 · Journal of Medical Primatology
26. P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy
    Sanjay U.C. Sankatsing, Jos H. Beijnen, Alfred H. Schinkel, Joep M. A. Lange, Jan M. Prins · 2004 · Antimicrobial Agents and Chemotherapy
27. The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro
    Shay Matalon, Brent E. Palmer, Marcel F. Nold, Antonio Furlan, Afework Kassu, Gianluca Fossati, Paolo Mascagni, Charles Anthony Dinarello · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
28. Dried Fluid Spots for HIV Type-1 Viral Load and Resistance Genotyping: A Systematic Review
    Raph L Hamers, Pieter Willem Smit, Wendy Susan Stevens, Rob Schuurman, Tobias F. Rinke de Wit · 2009 · Antiviral Therapy
29. Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection
    Mark R Dybul, Bertha Hidalgo, Tae‐Wook Chun, Michael Belson, Stephen A. Migueles, J. Shawn Justement, Betsey R. Herpin, Cheryl H. Perry, Claire W. Hallahan, Richard T. Davey et al. · 2002 · The Journal of Infectious Diseases
30. Maximum Likelihood Estimation in Dynamical Models of HIV
    Jérémie Guedj, Rodolphe Thiébaut, Daniel Commenges · 2007 · Biometrics
31. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients
    Jianqing J. Yu, Te Lang Wu, Megan K. Liszewski, Jihong Dai, William J. Swiggard, Clifford Baytop, Ian Frank, Bruce L. Levine, Wei Peter Yang, Theodore V. Theodosopoulos et al. · 2008 · Virology
32. The macrophage: a therapeutic target in HIV-1 infection
    Amit Kumar, Georges Herbein · 2014 · Molecular and Cellular Therapies
33. Suppression of HIV replication in the resting CD4 + T cell reservoir by autologous CD8 + T cells: Implications for the development of therapeutic strategies
    Tae‐Wook Chun, J. Shawn Justement, Susan L. Moir, Claire W. Hallahan, Linda A. Ehler, Shuying Liu, Mary E. McLaughlin, Mark R Dybul, JoAnn M. Mican, Anthony S. Fauci · 2001 · Proceedings of the National Academy of Sciences
34. Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
    Amy E. Baxter, Una O’Doherty, DE Kaufmann · 2018 · Retrovirology
35. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
    María Pernas, Laura Tarancón‐Díez, Esther Rodríguez‐Gallego, Josep Gómez, Júlia G. Prado, Concha Casado, Beatriz Domínguez-Molina, Isabel Olivares, Mayte Coiras, Agathe León et al. · 2017 · Journal of Virology
36. Impact of HIV-1 Envelope Conformation on ADCC Responses
    Jonathan Richard, Jérémie Prévost, Nirmin Alsahafi, Shilei Ding, Andrés Finzi · 2017 · Trends in Microbiology
37. The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
    Janne Tegder Martinsen, Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Martin Tolstrup, Ole Schmeltz Søgaard · 2020 · Frontiers in Immunology
38. Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes
    Philipp Kaiser, Béda Joos, Barbara Niederöst, Rainer K. Weber, Huldrych F. Günthard, Marek Fischer · 2007 · Journal of Virology
39. Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study
    Christoph Hess, Thomas Klimkait, Luregn Jan Schlapbach, Veronika Del Zenero, Salima Sadallah, Eliška Potluková, Gianmarco M. Balestra, Verena Werder, Christoph Schaefer, Manuel Battegay et al. · 2002 · The Lancet
40. The Gut Mucosal Viral Reservoir in HIV-Infected Patients Is Not the Major Source of Rebound Plasma Viremia following Interruption of Highly Active Antiretroviral Therapy
    Paula Lerner, Moraima Guadalupe, Richard M. Donovan, Jason Hung, Jason Flamm, Thomas P. Prindiville, Sumathi Sankaran‐Walters, Michael Syvanen, Joseph K. Wong, Michael D. George et al. · 2011 · Journal of Virology
41. Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment, and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent Anti-Human Immunodeficiency Virus (HIV) Agents
    Keduo Qian, Donglei Yu, Chin‐Ho Chen, Li Huang, Susan Lynne Morris-Natschke, Theodore J. Nitz, Karl Salzwedel, Mary Reddick, Graham P. Allaway, Kuo‐Hsiung Lee · 2009 · Journal of Medicinal Chemistry
42. Comparison of antiviral resistance across acute and chronic viral infections
    Stephen W. Mason, John P. DeVincenzo, Stephen Toovey, Jim Zhen Wu, Richard J. Whitley · 2018 · Antiviral Research
43. A Novel Mechanism of CD4 Lymphocyte Depletion Involves Effects of HIV on Resting Lymphocytes: Induction of Lymph Node Homing and Apoptosis Upon Secondary Signaling Through Homing Receptors
    Liqiang Wang, Jenny J-Y Chen, Benjamin B. Gelman, Rolf König, Miles W. Cloyd · 1999 · The Journal of Immunology
44. HIV-1-Infected CD4+ T Cells Facilitate Latent Infection of Resting CD4+ T Cells through Cell-Cell Contact
    Luis M. Agosto, Melissa Beth Herring, Walther Mothes, Andrew J. Henderson · 2018 · Cell Reports
45. FOXP3 mRNA Levels are Decreased in Peripheral Blood CD4+ Lymphocytes From HIV-Positive Patients
    P.A. Apoil, Bénédicte Puissant‐Lubrano, Francis Roubinet, Michel Abbal, Patrice Massip, Antoine Blancher · 2005 · JAIDS Journal of Acquired Immune Deficiency Syndromes
46. Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages
    Loyda Ylisastigui, Jean Vizzavona, Eugenia Drakopoulou, Pascale Paindavoine, Charles‐Félix Calvo, Marc Parmentier, Jean Claude Gluckman, Claudio Vita, Abdelaziz Benjouad · 1998 · AIDS
47. A Randomized Open-Label Study of 3- Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1–Infected Individuals
    Martin H. Markowitz, Teresa H. Evering, Donald Garmon, Marina F. Caskey, Melissa La Mar, Kristina Rodriguez, Vincent Sahi, Sarah Palmer, Nicole Prada, Hiroshi Mohri · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
48. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
    Amanda B. Macedo, Camille L. Novis, Caroline Maitan de Assis, Eric S. Sorensen, Paula Moszczynski, Szu-Han Huang, Yanqin Ren, Adam M. Spivak, Richard Brad Jones, Vicente Planelles et al. · 2018 · JCI Insight
49. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing
    Alice Cho, Christian Gaebler, Thiago Olveira, Víctor Ramos, Marwa Saad, Julio C. C. Lorenzi, Anna Gazumyan, Susan L. Moir, Marina F. Caskey, Tae‐Wook Chun et al. · 2022 · Proceedings of the National Academy of Sciences
50. Altering cell death pathways as an approach to cure HIV infection
    Andrew D. Badley, Amy M. Sainski, Fiona Wightman, Sharon R. Lewin · 2013 · Cell Death and Disease
51. Eradication of human immunodeficiency virus from brain reservoirs
    Avindra Nath · 2014 · Journal of NeuroVirology
52. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects
    Peter A. Anton, Ronald T. Mitsuyasu, Steven G. Deeks, David T. Scadden, Bridget K. Wagner, Christine A. Huang, Catherine A. Macken, Douglas D. Richman, Cindy Christopherson, Flavia Borellini et al. · 2003 · AIDS
53. Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing
    Carolyn R. Casella, Eric L. Rapaport, Terri Helman Finkel · 1999 · Journal of Virology
54. Human Immunodeficiency Virus in Semen Arises from a Genetically Distinct Virus Reservoir
    Ann Anderson Kiessling, L.M. Fitzgerald, Dawei Zhang, Heng Chhay, Doreen B. Brettler, Robert C. Eyre, Jeffrey Steinberg, K. McGowan, Randal A. Byrn · 1998 · AIDS Research and Human Retroviruses
55. HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
    Rutao Luo, Michael J. Piovoso, Javier Martínez‐Picado, Ryan Zurakowski · 2012 · PLoS ONE
56. A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes
    Gautam Kumar Sahu, Kyeongeun Lee, Jiaxiang Ji, Vivian Lam Braciale, Samuel Baron, Miles W. Cloyd · 2006 · Virology
57. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy
    Gabriela Khoury, Jenny L. Anderson, Rémi Fromentin, Wendy Hartogenesis, Miranda Z. Smith, Peter Bacchetti, Frederick M. Hecht, Nicolas Chomont, Paul U. Cameron, Steven G. Deeks et al. · 2016 · AIDS
58. Interleukin-7–treated naive T cells can be productively infected by T-cell–adapted and primary isolates of human immunodeficiency virus 1
    Carolyn M. Steffens, Elizabeth Z. Managlia, ALAN L. LANDAY, Lena Al‐Harthi · 2002 · Blood
59. New Betulinic Acid Derivatives for Bevirimat-Resistant Human Immunodeficiency Virus Type-1
    Zhao Dang, Phong Ho, Lei Zhu, Keduo Qian, Kuo‐Hsiung Lee, Li Huang, Chin‐Ho Chen · 2013 · Journal of Medicinal Chemistry
60. Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
    Ahmad R. Sedaghat, Janet D'Angelo Siliciano, Timothy P. Brennan, Claus O. Wilke, Robert F. Siliciano · 2007 · PLoS Pathogens
61. Measuring the latent reservoir in vivo
    Marta Massanella, Douglas D. Richman · 2016 · Journal of Clinical Investigation
62. HIV evolution and diversity in ART-treated patients
    Gert Uves van Zyl, Michael J. Bale, Mary F. Kearney · 2018 · Retrovirology
63. Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir
    Kyle D. Pedro, Andrew J. Henderson, Luis M. Agosto · 2019 · Virus Research
64. The forces driving clonal expansion of the HIV-1 latent reservoir
    Runxia Liu, Francesco Roberto Simonetti, Ya‐Chi Ho · 2020 · Virology Journal
65. The chromatin landscape at the HIV-1 provirus integration site determines viral expression
    Gerlinde Vansant, Heng‐Chang Chen, Eduard Valera Zorita, Kateřina Trejbalová, Dalibor Miklík, Guillaume J. P. Filion, Zeger Debyser · 2020 · Nucleic Acids Research
66. The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+T Cells
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2015 · The Journal of Infectious Diseases
67. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells
    Chi Ngai Chan, Benjamin Trinité, Caroline S. Lee, Saurabh Mahajan, Akanksha Anand, Dominik Wodarz, Steffanie Sabbaj, Anju Bansal, Paul Goepfert, David N. Levy · 2016 · Retrovirology
68. Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
    Natalia Soriano-Sarabia, Nancie M. Archin, Rosalie Bateson, Noelle Dahl, Amanda M. Crooks, JoAnn D. Kuruc, Carolina Garrido, David M. Margolis · 2015 · PLoS Pathogens
69. Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
    James B. Whitney, So‐Yon Lim, Christa Elyse Osuna, Jessica L. Kublin, Elsa Chen, Gyeol Yoon, Po-Ting Liu, Peter Abbink, Erica N. Borducchi, Alison L. Hill et al. · 2018 · Nature Communications
70. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS
    Wayne Anthony Marasco, Joyce LaVecchio, Aaron R. Winkler · 1999 · Journal of Immunological Methods
71. Direct HIV Cytopathicity Cannot Account for CD4 Decline in AIDS in the Presence of Homeostasis: A Worst-Case Dynamic Analysis
    Russell W. Anderson, Michael S. Ascher, Haynes W. Sheppard · 1998 · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
72. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus–infected patients
    Dianne Langford, Jennifer Marquie‐Beck, Sergio de Almeida, Deborah Lazzaretto, Scott Lee Letendre, Igor Grant, John Allen McCutchan, Eliezer Masliah, Ronald J. Ellis · 2006 · Journal of NeuroVirology
73. The clinical applications of genome editing in HIV
    Cathy X. Wang, Paula M. Cannon · 2016 · Blood
74. What Integration Sites Tell Us about HIV Persistence
    Stephen H. Hughes, John M. Coffin · 2016 · Cell Host & Microbe
75. A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection
    Charline Bacchus, Antoine Chéret, Véronique Avettand-Fènoël, Georges Nembot, Adeline Mélard, Catherine Blanc, Caroline Lascoux‐Combe, Laurence Slama, Thierry Allègre, Clotilde Allavena et al. · 2013 · PLoS ONE
76. Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals
    Sunpeng Wang, Patricia Lima Hottz, Mauro Schechter, Libin Rong · 2015 · PLoS Computational Biology
77. CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir
    Susan L. Moir, Réjean Lapointe, Angela Malaspina, Mario Ostrowski, Charsey E. Cole, Tae‐Wook Chun, Joseph W. Adelsberger, Michael Baseler, Patrick Hwu, Anthony S. Fauci · 1999 · Journal of Virology
78. The search for an HIV cure: tackling latent infection
    Stephen John Kent, Jeanette C. Reece, Janka Petravic, Alexey Martyushev, Marit Kramski, Robert De Rose, David A. Cooper, Anthony Dominic Kelleher, Sean Emery, Paul U. Cameron et al. · 2013 · The Lancet Infectious Diseases
79. Re-evaluating evolution in the HIV reservoir
    Daniel I. S. Rosenbloom, Alison L. Hill, Sarah B. Laskey, Robert F. Siliciano · 2017 · Nature
80. Myeloid Dendritic Cells Induce HIV-1 Latency in Non-proliferating CD4+ T Cells
    Vanessa A. Evans, Nitasha Kumar, Ali Filali, Francesco A. Procopio, Oleg Yegorov, Jean-Philippe Goulet, Suha M. Saleh, Elias K. Haddad, Candida da Fonseca Pereira, Paula C. Ellenberg et al. · 2013 · PLoS Pathogens
81. Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections
    Armita Nourmohammad, Jakub Otwinowski, Joshua B. Plotkin · 2016 · PLoS Genetics
82. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals
    Sharon R. Lewin, Jean Kirihara, Secondo Sonza, Lou Irving, JOHN S. MILLS, Suzanne M. Crowe · 1998 · AIDS
83. T-cell therapy of cytomegalovirus and human immunodeficiency virus infection
    Stanley R. Riddell · 2000 · Journal of Antimicrobial Chemotherapy
84. Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
    Aylin Yilmaz, Chris Verhofstede, Antonio D’Avolio, Victoria Watson, Lars Hagberg, Dietmar Fuchs, Bo Svennerholm, Magnus Gisslén · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
85. In vitro modeling of the HIV-macrophage reservoir
    Amanda M Brown, Hao Zhang, Peter Lopez, Carlos A. Pardo, Suzanne Gartner · 2006 · Journal of Leukocyte Biology
86. An integrative review of the efficacy of motivational interviewing in HIV management
    Phillip K. Dillard, Julie Ann Zuniga, Marcia McDonnell Holstad · 2016 · Patient Education and Counseling
87. Human retroviruses after 20 years: a perspective from the past and prospects for their future control
    Robert C. Gallo · 2002 · Immunological Reviews
88. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis
    Laura Fantuzzi, Filippo Belardelli, Sandra Gessani · 2003 · Journal of Leukocyte Biology
89. Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors
    Zhao Dang, Lei Zhu, Weihong Lai, Hal P. Bogerd, Kuo‐Hsiung Lee, Li Huang, Chin‐Ho Chen · 2016 · ACS Medicinal Chemistry Letters
90. Recent developments in the effort to cure HIV infection: going beyond N = 1
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2016 · Journal of Clinical Investigation
91. Safe two‐plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one‐step protocol
    Xiaobin Lü, Laurent M. P. F. Humeau, Vladimir Slepushkin, Gwendolyn K. Binder, Qiao Yu, Tatiana Slepushkina, Ziping Chen, Randall K. Merling, Brian Davis, Yung‐Nien Chang et al. · 2004 · The Journal of Gene Medicine
92. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
    Ariel Halper-Stromberg, Michel C. Nussenzweig · 2016 · Journal of Clinical Investigation
93. A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy
    Laura K. DeMaster, Xiaohe Liu, Jake VanBelzen, Benjamin Trinité, Lingjie Zheng, Luis M. Agosto, Stephen A. Migueles, Mark Connors, Lidia C. Sambucetti, David N. Levy et al. · 2015 · Journal of Virology
94. Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques
    Maud Mavigner, Jakob G. Habib, Claire Deléage, Elias P. Rosen, Cameron Mattingly, Katherine M. Bricker, Angela D. M. Kashuba, Franck Amblard, Raymond F. Schinazi, Benton Lawson et al. · 2018 · Journal of Virology
95. Between a shock and a hard place: challenges and developments in HIV latency reversal
    Jennifer M. Zerbato, Harrison V Purves, Sharon R. Lewin, Thomas A. Rasmussen · 2019 · Current Opinion in Virology
96. Infectious Virus Persists in CD4 + T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques
    Celina Monteiro Abreu, Rebecca T. Veenhuis, Claudia R. Avalos, Shelby Graham, Suzanne E. Queen, Erin N. Shirk, Brandon T. Bullock, Ming Li, Kelly A. Metcalf Pate, Sarah E. Beck et al. · 2019 · Journal of Virology
97. Reservoirs, Sanctuaries, and Residual Disease: The Hiding Spots of HIV-1
    Roger J. Pomerantz · 2003 · HIV Clinical Trials
98. Roles of autophagy in HIV infection
    Christina Dinkins, Manohar Pilli, John H. Kehrl · 2014 · Immunology and Cell Biology
99. Residual Viremia in Treated HIV+ Individuals
    Jessica M. Conway, Alan S. Perelson · 2016 · PLoS Computational Biology
100. DeepHINT: understanding HIV-1 integration via deep learning with attention
     Hailin Hu, An Xiao, Sai Zhang, Yangyang Li, Xuanling Shi, Tao Jiang, Linqi Zhang, Lei Zhang, Jianyang Zeng · 2018 · Bioinformatics